Sanofi (TSX:SNY)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of CAD 157.50 billion. The enterprise value is 178.47 billion.

Market Cap	157.50B
Enterprise Value	178.47B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	48.86%
Float	1.09B

Valuation Ratios

The trailing PE ratio is 12.52 and the forward PE ratio is 9.68.

PE Ratio	12.52
Forward PE	9.68
PS Ratio	2.09
PB Ratio	1.36
P/TBV Ratio	7.80
P/FCF Ratio	10.89
P/OCF Ratio	9.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.67, with an EV/FCF ratio of 12.33.

EV / Earnings	14.19
EV / Sales	2.37
EV / EBITDA	8.67
EV / EBIT	11.64
EV / FCF	12.33

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.

Current Ratio	1.09
Quick Ratio	0.66
Debt / Equity	0.28
Debt / EBITDA	1.58
Debt / FCF	2.26
Interest Coverage	18.17

Financial Efficiency

Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.

Return on Equity (ROE)	6.66%
Return on Assets (ROA)	4.65%
Return on Invested Capital (ROIC)	9.35%
Return on Capital Employed (ROCE)	9.80%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.00M
Profits Per Employee	168,050
Employee Count	74,846
Asset Turnover	0.36
Inventory Turnover	1.32

Taxes

In the past 12 months, Sanofi has paid 1.68 billion in taxes.

Income Tax	1.68B
Effective Tax Rate	17.33%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.71
Average Volume (20 Days)	6,851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of CAD 75.21 billion and earned 12.58 billion in profits. Earnings per share was 10.26.

Revenue	75.21B
Gross Profit	54.40B
Operating Income	15.54B
Pretax Income	9.69B
Net Income	12.58B
EBITDA	20.35B
EBIT	15.54B
Earnings Per Share (EPS)	10.26

Balance Sheet

The company has 12.35 billion in cash and 32.73 billion in debt, with a net cash position of -20.37 billion.

Cash & Cash Equivalents	12.35B
Total Debt	32.73B
Net Cash	-20.37B
Net Cash Per Share	n/a
Equity (Book Value)	115.44B
Book Value Per Share	95.15
Working Capital	4.20B

Cash Flow

In the last 12 months, operating cash flow was 17.31 billion and capital expenditures -2.84 billion, giving a free cash flow of 14.47 billion.

Operating Cash Flow	17.31B
Capital Expenditures	-2.84B
Free Cash Flow	14.47B
FCF Per Share	n/a

Margins

Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.

Gross Margin	72.34%
Operating Margin	20.66%
Pretax Margin	12.89%
Profit Margin	16.72%
EBITDA Margin	27.05%
EBIT Margin	20.66%
FCF Margin	19.24%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	61.08%
Buyback Yield	2.43%
Shareholder Yield	2.43%
Earnings Yield	7.99%
FCF Yield	9.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6